The Strategic Questions Reshaping the CDMO Map
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
False
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
April 11, 2025
3 min read
In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.
March 6, 2025
3 min read
And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.
March 10, 2025
3 min read
From geopolitical conflicts to cyber threats, CDMOs must rethink resilience.
March 26, 2025
3 min read
With competition for skilled employees in cell and gene therapy manufacturing high, companies need to ensure they are investing in training and mentorship.
False
Affiliations:
Specialties:
Areas of Expertise: